Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - Nasdaq - US00810F1066 - Common Stock - Currency: USD

5.86  -0.26 (-4.25%)

After market: 5.86 0 (0%)

Fundamental Rating

3

Taking everything into account, ASLE scores 3 out of 10 in our fundamental rating. ASLE was compared to 65 industry peers in the Aerospace & Defense industry. ASLE has a bad profitability rating. Also its financial health evaluation is rather negative. ASLE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ASLE had positive earnings in the past year.
ASLE had a negative operating cash flow in the past year.
Of the past 5 years ASLE 4 years were profitable.
In multiple years ASLE reported negative operating cash flow during the last 5 years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of ASLE (-0.88%) is worse than 64.62% of its industry peers.
With a Return On Equity value of -1.40%, ASLE is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROIC N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ASLE's Profit Margin has declined in the last couple of years.
ASLE's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 29.07%, ASLE is doing good in the industry, outperforming 67.69% of the companies in the same industry.
ASLE's Gross Margin has declined in the last couple of years.
ASLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.07%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

ASLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASLE has more shares outstanding than it did 1 year ago.
ASLE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ASLE has about the same debt to assets ratio.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 1.97 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
ASLE has a worse Altman-Z score (1.97) than 72.31% of its industry peers.
ASLE has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
ASLE has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ASLE outperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC10.98%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.54 indicates that ASLE has no problem at all paying its short term obligations.
ASLE's Current ratio of 4.54 is amongst the best of the industry. ASLE outperforms 90.77% of its industry peers.
ASLE has a Quick Ratio of 4.54. This is a bad value and indicates that ASLE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, ASLE is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 0.88
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ASLE have decreased strongly by -72.73% in the last year.
ASLE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.36% yearly.
ASLE shows a decrease in Revenue. In the last year, the revenue decreased by -7.63%.
The Revenue has been growing slightly by 0.45% on average over the past years.
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%

3.2 Future

Based on estimates for the next years, ASLE will show a very strong growth in Earnings Per Share. The EPS will grow by 74.93% on average per year.
Based on estimates for the next years, ASLE will show a quite strong growth in Revenue. The Revenue will grow by 8.59% on average per year.
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 195.33, ASLE can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ASLE is valued a bit more expensive than 63.08% of the companies in the same industry.
When comparing the Price/Earnings ratio of ASLE to the average of the S&P500 Index (27.30), we can say ASLE is valued expensively.
Based on the Price/Forward Earnings ratio of 10.08, the valuation of ASLE can be described as reasonable.
Based on the Price/Forward Earnings ratio, ASLE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ASLE is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 195.33
Fwd PE 10.08
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ASLE.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.05
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ASLE's earnings are expected to grow with 74.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)8.74
EPS Next 2Y74.93%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AERSALE CORP

NASDAQ:ASLE (7/11/2025, 8:00:00 PM)

After market: 5.86 0 (0%)

5.86

-0.26 (-4.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners51.82%
Inst Owner Change0%
Ins Owners8.6%
Ins Owner Change-445.19%
Market Cap274.60M
Analysts80
Price Target7.65 (30.55%)
Short Float %4.23%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-79.82%
Min EPS beat(2)-157.67%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-83.78%
Min EPS beat(4)-157.67%
Max EPS beat(4)-1.96%
EPS beat(8)1
Avg EPS beat(8)-60.01%
EPS beat(12)3
Avg EPS beat(12)-40.33%
EPS beat(16)7
Avg EPS beat(16)10.17%
Revenue beat(2)1
Avg Revenue beat(2)-13.38%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)1.22%
Revenue beat(4)1
Avg Revenue beat(4)-13.17%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)1.22%
Revenue beat(8)2
Avg Revenue beat(8)-16.53%
Revenue beat(12)3
Avg Revenue beat(12)-14.46%
Revenue beat(16)6
Avg Revenue beat(16)-7.92%
PT rev (1m)-6.25%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.78%
EPS NY rev (1m)-75.26%
EPS NY rev (3m)-73.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.45%
Valuation
Industry RankSector Rank
PE 195.33
Fwd PE 10.08
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.75
EV/EBITDA 25.05
EPS(TTM)0.03
EY0.51%
EPS(NY)0.58
Fwd EY9.92%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS6.84
BVpS8.67
TBVpS7.82
PEG (NY)N/A
PEG (5Y)8.74
Profitability
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.07%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score1
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 8.06
Cap/Depr 70.77%
Cap/Sales 4.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.54
Quick Ratio 0.88
Altman-Z 1.97
F-Score1
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.55%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year323.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.1%
OCF growth 3Y-47.9%
OCF growth 5YN/A